| Ms Carlyss Ann Kurtti, LPCC | |
|
151 S 4th St, Grand Forks, ND 58201-4715 | |
| (701) 235-4457 | |
| Not Available |
| Full Name | Ms Carlyss Ann Kurtti |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 151 S 4th St, Grand Forks, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073047395 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Carlyss Ann Kurtti, LPCC 151 S 4th St, Grand Forks, ND 58201-4715 Ph: () - | Ms Carlyss Ann Kurtti, LPCC 151 S 4th St, Grand Forks, ND 58201-4715 Ph: (701) 235-4457 |
News Archive
Cerberus Capital Management is poised to purchase Caritas Christi Health Care. This morning, at a Massachusetts Supreme Judicial Court hearing, Caritas and Cerberus face the final hurdle in an approval process that began in the spring.
Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).
A new study suggests that extra iron for infants who don't need it might delay development - results that fuel the debate over optimal iron supplement levels and could have huge implications for the baby formula and food industry.
News outlets details the ongoing back-and-forth as Community Health Systems continues its pursuit of rival hospital group Tenet Healthcare Corp. Meanwhile, The Boston Globe details what may be in store for Caritas' hospital system.
AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.
› Verified 2 days ago
Courtney Salomonson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1712 Continental Dr Apt 215, Grand Forks, ND 58201 Phone: 605-237-2427 | |
Amanda Weston Caillier, LAPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 340 Division Avenue, Grand Forks, ND 58201 Phone: 218-779-0134 | |
Denae Haagenson, M.ED, LPCC, NCC, LP Counselor Medicare: Not Enrolled in Medicare Practice Location: 412 Demers Ave, Grand Forks, ND 58201 Phone: 701-271-1632 Fax: 701-235-7359 | |
Shelby Hildenbrand, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1726 S Washington St Ste 33a, Grand Forks, ND 58201 Phone: 701-746-4584 Fax: 651-925-0057 | |
Cheryl Repp-tredway, LPCC, LCPC Counselor Medicare: Medicare Enrolled Practice Location: 4700 S Washington St Ste G, Grand Forks, ND 58201 Phone: 701-205-3000 | |
Deborah Lynn Davis, LPCC, LMAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2424 32nd Ave S, Suite 202, Grand Forks, ND 58201 Phone: 701-746-6336 Fax: 701-772-1030 |